Clinical trials
COVID-19 trials in Italy with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
58 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 28 |
| 2021 | 23 |
| 2022 | 3 |
| 2023 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 29 |
| Unknown status | 20 |
| Terminated | 5 |
| Recruiting | 3 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 4 |
| Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | 3 |
| Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo | 2 |
| Azienda di Servizi alla Persona di Pavia | 2 |
| IRCCS Azienda Ospedaliero-Universitaria di Bologna | 2 |
| IRCCS Policlinico S. Donato | 2 |
| IRCCS Sacro Cuore Don Calabria di Negrar | 2 |
| Istituti Clinici Scientifici Maugeri SpA | 2 |
| Mario Negri Institute for Pharmacological Research | 2 |
| University of Padova | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| COVID-19 | 58 |
| Coronavirus Infections | 8 |
| Post-Acute COVID-19 Syndrome | 5 |
| Pneumonia | 4 |
| Fatigue | 3 |
| Respiratory Insufficiency | 3 |
| Anxiety Disorders | 2 |
| Cytokine Release Syndrome | 2 |
| Dysbiosis | 2 |
| Inflammation | 2 |
Trials
Showing 1 to 25 of 58. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.